Workflow
G1 Therapeutics(GTHX) - 2022 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) Delaware 26-3648180 ( State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 700 Park Offices Drive, Suite 200 Research Triangle Park, NC 27709 (Address of principal executive offices including zip code) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SE ...